latest news releases from the newsroom
Crew Gold Corporation
Crew Gold Corporation: Notification of Trade
LONDON, March 28, 2006 (PRIMEZONE) -- Crew Crew Gold Corporation ("Crew") (TSX:CRU) (Oslo:CRU) (Frankfurt:KNC) (Other OTC:CRUGF): As part of the recently announced receipt of private placement subscriptions, Jan A Vestrum, President and CEO of Crew, has been allocated 352,000 shares in Crew at a price of NOK 13 per share.
Investorstockalert.com Announces Profile Launch of Execute Sports, Inc.
WELLINGTON, Fla., March 28, 2006 (PRIMEZONE) -- Ken Weiner, Publisher of Investorstockalert.com, today announced profile coverage of Execute Sports, Inc. (OTCBB:EXCS). The profile is a comprehensive look at the company's growth initiative. You can view the complete profile at http://www.investorstockalert.com/investor-stock/profiles/excs/index.php
Shazamstocks.com Announces Profile Launch of Lyric Jeans, Inc.
WELLINGTON, Fla., March 28, 2006 (PRIMEZONE) -- Ken Weiner, Publisher of Shazamstocks.com, today announced profile coverage of Lyric Jeans, Inc. (Pink Sheets:LYJN). The profile is a comprehensive look at the company's growth initiative. You can view the complete profile at http://www.shazamstocks.com/profiles/lyjn/index.php.
StockInterview.com Uncovers a 20-Year Old Scientific 'Accident' Which May Lead to a Breakthrough Ovarian Cancer Treatment
SARASOTA, Fla., March 28, 2006 (PRIMEZONE) -- A twenty-year secret has come to light. While working on the development of an imaging technology to study cancer tumors, University of Alberta Professor Emeritus Dr. Antoine Noujaim stumbled across a potentially major breakthrough in the treatment of ovarian cancer patients. In a taped interview, Dr. Noujaim told StockInterview.com, "We sent some of these antibodies to Professor Richard Baum in Germany for imaging of ovarian cancer patients. Dr. Baum phoned back, after some time, and told me, 'The patients I was imaging here had advanced ovarian cancer and some of them seem to have done quite well after we gave them a couple of shots (of the B43.13 antibody, the clinical name for OvaRex(r) MAb) to image the tumor.' I thought he was joking with me."
Northrop Grumman Corp.
Northrop Grumman Brings Engineering to Community Classrooms
ROLLING MEADOWS, Ill., March 28, 2006 (PRIMEZONE) -- In support of the nationwide student outreach program, Discover Engineering (Discover "E"), Northrop Grumman Corporation (NYSE: NOC) is sending a total of 43 engineering staff members into 20 different Chicago-area schools to give students a better understanding of the contribution engineers make to society.
Sovereign Bancorp Announces ATM Branding Agreement with Cardtronics
PHILADELPHIA, March 28, 2006 (PRIMEZONE) -- Sovereign Bank and Cardtronics Inc. of Houston, Texas, have entered into an agreement that will enable Sovereign to brand nearly 900 cash dispensing Automatic Teller Machines (ATMs) in CVS/pharmacy locations across the northeastern United States including Massachusetts, Rhode Island, northern Connecticut, New Hampshire, eastern Pennsylvania and southern New Jersey. Installations will be completed over the next few months. Sovereign will also have the opportunity to brand ATMs at any new CVS/pharmacy locations within the same footprint. In addition, all Sovereign ATMs in CVS/pharmacy stores will be surcharge-free to Sovereign customers - just like Sovereign's on-premise ATMs.
StockGuru.com Announces Profile Coverage of China Wireless
DALLAS, March 28, 2006 (PRIMEZONE) -- John Pentony, Publisher of StockGuru.com, announced today that the web site has initiated profile coverage of China Wireless Communications, Inc. (OTCBB:CWLC). China Wireless, headquartered in Denver, CO, is focusing its efforts on becoming a premier information technology company in the People's Republic of China (China). The company provides business solutions to clients which include systems integration, broadband data services, support for Internet access and Voice over IP in China.
WEST PALM BEACH, Fla., March 28, 2006 (PRIMEZONE) -- Titleinsurance.com, the first and only source for consumers to comparison shop for title insurance, today announces its official launch.
co.don AG Signs Exclusive Distribution Agreement for Germany
TELTOW, Germany, March 28th, 2006 - co.don(r) AG (ISIN DE000517360 3), an Tissue Engineering and Regenerative Medicine biopharmaceutical company that develops, manufactures and markets innovative autologous cartilage and bone growth and repair therapeutics, announced today an exclusive three-year distribution agreement with ORMED GmbH & Co. KG -- to market co.don chondrosphere(r) and co.don chondrotransplant(r) DISC in Germany.co.don chondrosphere(r) is a three-dimensional in vitro cultured autologous matrix-supported articular cartilage without foreign carrier materials of animal and synthetic origin and with very easy surgical application avoiding defect covering, developed to regenerate and to replace removed or missing joint cartilage. ORMED GmbH & Co. KG will market co.don chondrosphere(r) under the brand ARTROcell 3D.